Low molecular weight heparin as an anticoagulation strategy for left ‐sided ablation procedures

ConclusionAdministration of low molecular weight heparin provides predictable anticoagulation and equally safe as unfractionated heparin when administered to patients post left‐sided ablation. A secondary gain has been reduction of procedural costs by elimination of the previously required inpatient observation stay.

Source: Congenital Heart Disease - September 1, 2017 Category: Cardiology Authors: Karen Hinsley, Margaret Evans ‐Langhorst, Courtney Porter, Stephanie Chandler, Christina VanderPluym, John Triedman, Vassilios J. Bezzerides Tags: ORIGINAL ARTICLE Source Type: research